Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Dougados

Showing results (391-400 of 600) with videos related to

Pageof 60
Sort By:
Annals of the Rheumatic Diseases|March 31, 2017
Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritisKaterina Chatzidionysiou, Sharzad Emamikia, Jackie Nam, et al.
The Journal of Rheumatology|July 5, 2007
Effect of a collective educational program for patients with rheumatoid arthritis: a prospective 12-month randomized controlled trialJanine-Sophie Giraudet-Le Quintrec, Anne Mayoux-Benhamou, Philippe Ravaud, et al.
Rheumatology (Oxford, England)|September 2, 2017
Drivers of patient global assessment in patients with rheumatoid arthritis who are close to remission: an analysis of 1588 patientsRicardo J O Ferreira, Maxime Dougados, John R Kirwan, et al.
Clinical and Experimental Rheumatology|January 24, 2020
Safety of surgery in patients with rheumatoid arthritis treated with tocilizumab: data from the French (REGistry -RoAcTEmra) Regate registryJacques Morel, Marie Locci, Frédéric Banal, et al.
Annals of the Rheumatic Diseases|April 8, 2020
Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging studyDésirée van der Heijde, Lianne S Gensler, Atul Deodhar, et al.
Clinical and Experimental Rheumatology|January 9, 2019
Acute anterior uveitis in spondyloarthritis: a monocentric study of 301 patientsCamelia Frantz, Agnes Portier, Adrien Etcheto, et al.
Rheumatology and Therapy|June 13, 2020
Induction of Sustained Clinical Remission in Early Axial Spondyloarthritis Following Certolizumab Pegol Treatment: 48-Week Outcomes from C-OPTIMISERobert Landewé, Désirée van der Heijde, Maxime Dougados, et al.
Arthritis Care & Research|October 20, 2022
Identification of Symptom Phenotypes of Hand Osteoarthritis Using Hierarchical Clustering: Results From the DIGICOD CohortMarie Binvignat, Gabriel Pires, Nicolas Tchitchek, et al.
Human Molecular Genetics|July 6, 2004
Significant linkage to spondyloarthropathy on 9q31-34Corinne Miceli-Richard, Habib Zouali, Roula Said-Nahal, et al.
RMD Open|April 14, 2017
Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritisPaul Emery, Ricardo Blanco, Jose Maldonado Cocco, et al.
Pageof 60

Showing results (391-400 of 600) with videos related to

Sort By:
Pageof 60
Annals of the Rheumatic Diseases|March 31, 2017
Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritisKaterina Chatzidionysiou, Sharzad Emamikia, Jackie Nam, et al.
The Journal of Rheumatology|July 5, 2007
Effect of a collective educational program for patients with rheumatoid arthritis: a prospective 12-month randomized controlled trialJanine-Sophie Giraudet-Le Quintrec, Anne Mayoux-Benhamou, Philippe Ravaud, et al.
Rheumatology (Oxford, England)|September 2, 2017
Drivers of patient global assessment in patients with rheumatoid arthritis who are close to remission: an analysis of 1588 patientsRicardo J O Ferreira, Maxime Dougados, John R Kirwan, et al.
Clinical and Experimental Rheumatology|January 24, 2020
Safety of surgery in patients with rheumatoid arthritis treated with tocilizumab: data from the French (REGistry -RoAcTEmra) Regate registryJacques Morel, Marie Locci, Frédéric Banal, et al.
Annals of the Rheumatic Diseases|April 8, 2020
Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging studyDésirée van der Heijde, Lianne S Gensler, Atul Deodhar, et al.
Clinical and Experimental Rheumatology|January 9, 2019
Acute anterior uveitis in spondyloarthritis: a monocentric study of 301 patientsCamelia Frantz, Agnes Portier, Adrien Etcheto, et al.
Rheumatology and Therapy|June 13, 2020
Induction of Sustained Clinical Remission in Early Axial Spondyloarthritis Following Certolizumab Pegol Treatment: 48-Week Outcomes from C-OPTIMISERobert Landewé, Désirée van der Heijde, Maxime Dougados, et al.
Arthritis Care & Research|October 20, 2022
Identification of Symptom Phenotypes of Hand Osteoarthritis Using Hierarchical Clustering: Results From the DIGICOD CohortMarie Binvignat, Gabriel Pires, Nicolas Tchitchek, et al.
Human Molecular Genetics|July 6, 2004
Significant linkage to spondyloarthropathy on 9q31-34Corinne Miceli-Richard, Habib Zouali, Roula Said-Nahal, et al.
RMD Open|April 14, 2017
Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritisPaul Emery, Ricardo Blanco, Jose Maldonado Cocco, et al.
Pageof 60